Antiproliferative effect of pheophorbide a-mediated photodynamic therapy and its synergistic effect with doxorubicin on multiple drug-resistant uterine sarcoma cell MES-SA/Dx5

Drug and Chemical Toxicology

Volumn 36, Issue 4, 2013, Pages 474-483

  Cheung, Karen Ka Yan ^a   Chan, Judy Yuet Wa ^a,b   Fung, Kwok Pui ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Doxorubicin; Multidrug resistance; Pheophorbide a; Photodynamic therapy

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN; PHEOPHORBIDE A; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CELL DEATH; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN EXPRESSION; SARCOMA CELL; UTERUS SARCOMA;

ALPHA-TOCOPHEROL; ANALYSIS OF VARIANCE; CELL LINE, TUMOR; CELL PROLIFERATION; CHLOROPHYLL; DNA FRAGMENTATION; DNA PRIMERS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG SYNERGISM; FEMALE; FLOW CYTOMETRY; HUMANS; P-GLYCOPROTEIN; PHOTOCHEMOTHERAPY; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA; UTERINE NEOPLASMS;

EID: 84883383914     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480545.2013.776584     Document Type: Article

References (25)

1. Amant F, Coosemans A, Debiec-Rychter M, et al. (2009). Clinical management of uterine sarcomas. Lancet Oncol 10:1188-98.
2. Bidwell 3rd GL, Davis AN, Fokt I, et al. (2007). A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance. Invest New Drugs 25:313-26.
3. Cai Y, Lu J, Miao Z, et al. (2007). Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells. Cancer Biol Ther 6:1794-9.
4. Chan JY, Tang PM, Hon, PM, et al. (2006). Pheophorbide a, a major antitumor component purified from Scutellaria barbata, induces apoptosis in human hepatocellular carcinoma cells. Planta Med 72: 28-33.
5. Choi RJ, Ngoc TM, Bae K, et al. (2012). Anti-inflammatory properties of anthraquinones and their relationship with the regulation of P-glycoprotein function and expression. Eur J Pharm Sci 48:272-81.
6. Dolmans DE, Fukumura D, Jain RK. (2003). Photodynamic therapy for cancer. Nat Rev Cancer 3:380-7.
7. Droge W. (2002). Free radicals in the physiological control of cell function. Physiol Rev 82:47-95.
8. Emanuelov AK, Shainberg A, Chepurko Y, et al. (2010). Adenosine A3 receptor-mediated cardioprotection against doxorubicin-induced mitochondrial damage. Biochem Pharmacol 79:180-7.
9. Gilleron M, Marechal X, Montaigne D, et al. (2009). NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis. Biochem Biophys Res Commun 388:727-31.
10. Golab J, Nowis D, Skrzycki M, et al. (2003). Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor. J Biol Chem 278:407-14.
11. Klamt F, Passos DT, Castro MA, et al. (2008). Inhibition of MDR1 expression by retinol treatment increases sensitivity to etoposide (VP16) in human neoplasic cell line. Toxicol In Vitro 22:873-8.
12. Lage H. (2008). An overview of cancer multi-drug resistance: a still unsolved problem. Cell Mol Life Sci 65:3145-67.
13. Longley DB, Johnston PG. (2005). Molecular mechanisms of drug resistance. J Pathol 205:275-92.
14. MacDonald IJ, Dougherty TJ. (2001). Basic principles of photodynamic therapy. J Porphyr Phthalocya 5:105-29.
15. Marmur ES, Schmults CD, Goldberg DJ. (2004). A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 30:264-71.
16. Nemani D, Mitra N, Guo M, Lin L. (2008). Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Gynecol Oncol 111:82-8.
17. Olson LE, Bedja D, Alvey SJ, et al. (2003). Protection from doxorubicininduced cardiac toxicity in mice with a null allele of carbonyl reductase 1. Cancer Res 63:6602-6.
18. Papadimitriou CA, Zorzou MP, Markaki S, et al. (2007). Anthracyclinebased adjuvant chemotherapy in early-stage uterine sarcomas: longterm results of a single institution experience. Eur J Gynaecol Oncol 28:109-16.
19. Qiang YG, Zhang XP, Li J, Huang Z. (2006). Photodynamic therapy for malignant and non-malignant diseases: clinical investigation and application. Chin Med J (Engl) 119:845-57.
20. Simunek T, Sterba M, Popelova O, et al. (2009). Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep 61:154-71.
21. Sinha AK, Anand S, Ortel BJ, et al. (2006). Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer 95:485-95.
22. Tang PM, Chan JY, Au SW, et al. (2006). Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma. Cancer Biol Ther 5:1111-16.
23. Tang PM, Liu XZ, Zhang DM, et al. (2009). Pheophorbide a-based photodynamic therapy induces apoptosis via mitochondrialmediated pathway in human uterine carcinosarcoma. Cancer Biol Ther 8:533-9.
24. Wartenberg M, Hoffmann E, Schwindt H, et al. (2005). Reactive oxygen species-linked regulation of the multi-drug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids. FEBS Lett 579:4541-9.
25. Yang L, Wei Y, Xing D, Chen Q. (2010). Increasing the efficiency of photodynamic therapy by improved light delivery and oxygen supply using an anticoagulant in a solid tumor model. Lasers Surg Med 42: 671-9.